» Articles » PMID: 19139562

Loss of Viral Fitness and Cross-recognition by CD8+ T Cells Limit HCV Escape from a Protective HLA-B27-restricted Human Immune Response

Abstract

There is an association between expression of the MHC class I molecule HLA-B27 and protection following human infection with either HIV or HCV. In both cases, protection has been linked to HLA-B27 presentation of a single immunodominant viral peptide epitope to CD8+ T cells. If HIV mutates the HLA-B27-binding anchor of this epitope to escape the protective immune response, the result is a less-fit virus that requires additional compensatory clustered mutations. Here, we sought to determine whether the immunodominant HLA-B27-restricted HCV epitope was similarly constrained by analyzing the replication competence and immunogenicity of different escape mutants. Interestingly, in most HLA-B27-positive patients chronically infected with HCV, the escape mutations spared the HLA-B27-binding anchor. Instead, the escape mutations were clustered at other sites within the epitope and had only a modest impact on replication competence. Further analysis revealed that the cluster of mutations is required for efficient escape because a combination of mutations is needed to impair T cell recognition of the epitope. Artificially introduced mutations at the HLA-B27-binding anchors were found to be either completely cross-reactive or to lead to substantial loss of fitness. These results suggest that protection by HLA-B27 in HCV infection can be explained by the requirement to accumulate a cluster of mutations within the immunodominant epitope to escape T cell recognition.

Citing Articles

analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation.

Baig S, Berikkara A, Khalid R, Subhan S, Abbas T, Abidi S Front Microbiol. 2025; 15:1498069.

PMID: 39881992 PMC: 11774985. DOI: 10.3389/fmicb.2024.1498069.


High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors.

Caragea A, Ursu R, Maruntelu I, Tizu M, Constantinescu A, Talangescu A Int J Mol Sci. 2024; 25(16).

PMID: 39201523 PMC: 11354460. DOI: 10.3390/ijms25168837.


SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.

Li X, Mi Z, Liu Z, Rong P Front Microbiol. 2024; 15:1334152.

PMID: 38939189 PMC: 11208693. DOI: 10.3389/fmicb.2024.1334152.


Portable and Air Conditioner-Based Bio-Protection Devices to Prevent Airborne Infections in Acute and Long-Term Healthcare Facilities, Public Gathering Places, Public Transportation, and Similar Entities.

Pisharodi M Cureus. 2024; 16(3):e55950.

PMID: 38469370 PMC: 10926937. DOI: 10.7759/cureus.55950.


[The role of HLA-B27 in the pathogenesis and diagnosis of axial spondyloarthritis : 50 years after discovery of the strong genetic association].

Braun J, Rudwaleit M, Sieper J Z Rheumatol. 2023; 83(2):125-133.

PMID: 38112753 DOI: 10.1007/s00393-023-01460-0.


References
1.
Neumann-Haefelin C, Frick D, Wang J, Pybus O, Salloum S, Narula G . Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. J Virol. 2008; 82(7):3438-51. PMC: 2268453. DOI: 10.1128/JVI.01700-07. View

2.
Timm J, Li B, Daniels M, Bhattacharya T, Reyor L, Allgaier R . Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology. 2007; 46(2):339-49. DOI: 10.1002/hep.21702. View

3.
Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg H, Killinger T . Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology. 2006; 43(3):563-72. DOI: 10.1002/hep.21049. View

4.
Lohmann V, KORNER F, Koch J, Herian U, Theilmann L, Bartenschlager R . Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999; 285(5424):110-3. DOI: 10.1126/science.285.5424.110. View

5.
Friebe P, Boudet J, Simorre J, Bartenschlager R . Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol. 2004; 79(1):380-92. PMC: 538730. DOI: 10.1128/JVI.79.1.380-392.2005. View